Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
Clinical trial NCT02841150 · COMPLETED
Trial details
- NCT number
- NCT02841150
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-08-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.